Since IPF patients and mice were characterized by the overexpression of Sart1 in macrophages, we next sought to assess the therapeutic effect of Sart1 siRNA on pulmonary fibrosis model by employing Sart1 siRNA-loaded liposomes. This evidence concerns the gene SART1 and idiopathic pulmonary fibrosis.